
Keywords: سازمان غذا و دارو; AIH; autoimmunelike hepatitis; ALF; acute liver failure; ALT; alanine aminotransferase; CNS; central nervous system; DI-AIH; drug-induced autoimmunelike hepatitis; DILI; drug-induced liver injury; DILIN; Drug Induced Liver Injury Network; FDA; Food and Dr